Hetero’s drug to treat covid gets DCGI nod

Drugmaker Hetero on Monday said its generic version of Roche Holding AG’s tocilizumab, an immunosuppressant used to treat severe cases of covid-19, has been given emergency-use approval in India

from mint - Science https://ift.tt/3zSwtOt
https://ift.tt/eA8V8J